About 14,923 results

ALLMedicine™ Hypoglycemia Center

Research & Reviews  4,817 results

The Bihormonal Bionic Pancreas Improves Glycemic Control in Individuals With Hyperinsul...
Diabetes Care; Rayannavar A, Mitteer LM et. al.

Sep 15th, 2021 - To determine whether the bihormonal bionic pancreas (BHBP) improves glycemic control and reduces hypoglycemia in individuals with congenital hyperinsulinism (HI) and postpancreatectomy diabetes (PPD) compared with usual care (UC). Ten subjects wit...

Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure.
Annual Review of Pharmacology and Toxicology; Shah KS, Fang JC

Sep 14th, 2021 - Sodium-glucose cotransporter 2 (SGLT2) inhibitors improve blood glucose control by blocking renal glucose reabsorption with little subsequent risk of hypoglycemia. Consequently, there are decreases in plasma volume, body weight, and blood pressure...

A phenotypic expansion of TRNT1 associated sideroblastic anemia with immunodeficiency, ...
American Journal of Medical Genetics. Part A; Odom J, Amin H et. al.

Sep 13th, 2021 - Sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD; MIM #616084) is an autosomal recessive disorder of mitochondrial and cytosolic tRNA processing caused by pathogenic, biallelic variants in TRNT1. Other features of ...

Chasing the Offending Medication: When Antidepressants Lead to Hypoglycemia.
Journal of Clinical Psychopharmacology; Singh N, Khetan A et. al.

Sep 12th, 2021 - Chasing the Offending Medication: When Antidepressants Lead to Hypoglycemia.|2021|Singh N,Khetan A,Gupta R,|

Childhood diabetes and sleep.
Pediatric Pulmonology; Monzon AD, Patton SR et. al.

Sep 11th, 2021 - Sleep modulates glucose metabolism, both in healthy states and in disease. Alterations in sleep duration (insufficient and excessive) and obstructive sleep apnea may have reciprocal ties with obesity, insulin resistance and Type 2 diabetes, as dem...

see more →

Guidelines  9 results

Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation St...
JAMA , Davidson KW et. al.

Aug 11th, 2021 - Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are us...

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 19th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement ...
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Pugliese G, Penno G et. al.

Oct 7th, 2019 - This joint document of the Italian Diabetes Society and the Italian Society of Nephrology reviews the natural history of diabetic kidney disease (DKD) in the light of the recent epidemiological literature and provides updated recommendations on an...

Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British...
Journal of Human Lactation : Official Journal of Internat... Hawdon JM

May 6th, 2019 - Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British Association of Perinatal Medicine Framework for Practice, 2017.|2019|Hawdon JM,|prevention & control,prevention & control,standards,

Choosing Wisely in pediatric anesthesia: An interpretation from the German Scientific W...
Paediatric Anaesthesia; Becke K, Eich C et. al.

Jun 1st, 2018 - Inspired by the Choosing Wisely initiative, a group of pediatric anesthesiologists representing the German Working Group on Paediatric Anaesthesia (WAKKA) coined and agreed upon 10 concise positive ("dos") or negative ("don'ts") evidence-based rec...

see more →

Drugs  181 results see all →

Clinicaltrials.gov  19 results

Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)

Sep 10th, 2021 - I. RATIONALE AND SPECIFIC AIMS CHANGING THE NATURAL HISTORY OF TYPE 2 DIABETES - "CHANGE" STUDY I.A. RATIONALE The investigators will test the hypothesis that maintenance of normoglycemia can prevent the typical worsening of hyperglycemia in early...

Empagliflozin for the Treatment of Postprandial Hypoglycemia

Sep 5th, 2021 - Postprandial hypoglycemia is a debilitating medical complication after bariatric surgery for which no approved pharmacological treatment exists. The prevalence of hypoglycemia in bariatric patients ranges from 0.5 % severe episodes up to 56 % and ...

Time Limited Eating in Type 1 Diabetes

Sep 1st, 2021 - This will be a two-armed study with an intervention and control group. Feasibility and acceptability will be assessed by using questionnaires. Safety will be indicated by hypoglycemia occurrence. β-cell function and insulin sensitivity will be eva...

Fetal Cardiac Function Parameters and HbA1c as Screening for Gestational Diabetes Mellitus

Aug 25th, 2021 - Gestational diabetes mellitus (GDM) is the onset of carbohydrate intolerance that affects up to 6-9% of pregnancies. A diagnosis of GDM conveys numerous implications for the health of the mother and the fetus if not properly identified and/or trea...

The Effect of Fasting on Serum Osmolarity in Diabetic Patients

May 19th, 2020 - Till recently, it was assumed that patients with type 2 diabetes have to eat frequently, especially to avoid hypoglycemia, which is still true if they are using sulphonylurea or insulin. Especially because patients with diabetes often have one or ...

see more →

News  939 results

Nocturnal Hypoglycemia Halved With Insulin Degludec vs Glargine, Confirms Study in Type 1 Diabetes

Jul 6th, 2021 - Patients with type 1 diabetes who used insulin degludec as their basal insulin had fewer than half the number of nocturnal hypoglycemia events, compared with patients who used insulin glargine U100, in a head-to-head crossover study with 51 patien...

Implanted Glucose Monitor for Diabetes Accurate Up to 6 Months

Jun 28th, 2021 - A next-generation implanted continuous glucose monitor (Eversense, Senseonics/Ascensia) is accurate and safe for up to 6 months of use, new data suggest. The first-generation 90-day Eversense was approved by the US Food and Drug Administration in ...

Fast Five Quiz: Type 2 Diabetes Incretin-Based Therapy

Jun 24th, 2021 - Incretin-based agents were introduced into the diabetes treatment landscape to address postprandial glucose control. In the postprandial phase, nutrients are ingested; in response, incretins, such as glucagon-like peptide 1 (GLP-1) and gastric inh...

Fast Five Quiz: Type 2 Diabetes Incretin-Based Therapy

Jun 24th, 2021 - Incretin-based agents were introduced into the diabetes treatment landscape to address postprandial glucose control. In the postprandial phase, nutrients are ingested; in response, incretins, such as glucagon-like peptide 1 (GLP-1) and gastric inh...

Hypoglycemia, Hypertension Tied to Cognitive Decline in Type 1 Diabetes

Jun 14th, 2021 - NEW YORK (Reuters Health) - Patients with type 1 diabetes may be at greater risk of cognitive decline as they age, especially if they have high blood sugar, bouts of severe hypoglycemia and/or high blood pressure, researchers say. For individuals ...

see more →

Patient Education  4 results see all →